Tuberous Sclerosis

Rare Disease·MeSH: Tuberous Sclerosis

6 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
afinitor	Novartis AG (NVS)
Epidiolex / Epidyolex	Jazz Pharmaceuticals plc (JAZZ)

Phase 3(1)

Drug	Company
ANAVEX®2-73	ANAVEX LIFE SCIENCES CORP. (AVXL)

Phase 2(1)

Drug	Company
GWP42003-P	Jazz Pharmaceuticals plc (JAZZ)

Phase 4(2)

Drug	Company
Cannabidiol Oral Solution [Epidiolex]	Jazz Pharmaceuticals plc (JAZZ)
Epidiolex 100 mg/mL Oral Solution	Jazz Pharmaceuticals plc (JAZZ)

BioSniper tracks 6 drugs in development for Tuberous Sclerosis across 3 companies.

There are 3 clinical trials targeting Tuberous Sclerosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.